Glycosylation Of Antibodies

Antibodies, like many other natural proteins, are normally decorated with sugars. Optimizing the pattern of sugars associated with synthetic antibodies can have an enormous impact on their therapeutic efficacy. This technology, known as glycoengineering, is the focus of the Roche research centre in Schlieren, Switzerland.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement